Randomized phase II study comparing the efficacy and safety of SOX versus mFOLFOX6 as neoadjuvant chemotherapy without radiotherapy for locally advanced rectal cancer (KSCC1301).
Keisuke MiwaEiji OkiMasanobu EnomotoKeisuke IharaKoji AndoFumihiko FujitaMasahiro TominagaShinichiro MoriGoro NakayamaMototsugu ShimokawaHiroshi SaekiHideo BabaMasaki MoriYoshito AkagiPublished in: BMC cancer (2021)
Date of enrolment of the first participant to the trial: 3rd Oct 2013; This study was registered in the UMIN clinical trials registry on 14th Aug, 2013. (Prospectively registered, UMIN-CTR number UMIN000011486). https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr.cgi?function=brows&recptno=R000013441&language=J.
Keyphrases
- locally advanced
- phase ii study
- neoadjuvant chemotherapy
- rectal cancer
- clinical trial
- phase iii
- phase ii
- open label
- squamous cell carcinoma
- radiation therapy
- double blind
- sentinel lymph node
- placebo controlled
- stem cells
- study protocol
- transcription factor
- health insurance
- minimally invasive
- autism spectrum disorder
- diabetic retinopathy
- randomized controlled trial
- early stage
- lymph node